“Cardiac toxicity associated with HCV direct antiviral agents: Heart in HCV DAAs therapy”, Mediterr J Hematol Infect Dis, vol. 10, no. 1, p. e2018069, Oct. 2018, doi: 10.4084/mjhid.2018.069.